Paris and Manchester, Sept. 8, 2026 — Yourgene Health, part of the Novacyt Group, announced Tuesday the commercial launch of its IVDR-certified Yourgene® Insight DPYD assay, a pharmacogenetic test designed to help clinicians identify cancer patients at heightened risk of severe toxicity from commonly
Read More
